Loading...


Lyophilization and Protein Formulation
siRNA - Protein Synthesis

-

RNAi: Silencing never sounded better

Votes:34 Comments:0
It also offers the flexibility to shuttle hairpin inserts from one vector to another depending on the researcher's needs. "There are different variations of plasmid vectors in terms of promoters and READ MORE
http://www.nature.com/nmeth/journal/v1/n1/full/nmeth1004-79.html

RNAi Therapy: Antibodies guide the way

Votes:10 Comments:0
A weakness of the fusion proteins used by the authors is that purification and refolding steps are needed for each recombinant fusion protein. This might be addressed by the production of soluble anti READ MORE
http://www.nature.com/gt/journal/vaop/ncurrent/full/3302634a.html

Are siRNAs Specific Enough to Become Therapeutics?

Votes:5 Comments:0
Thus, the microarray patterns from two different siRNAs targeting the same mRNA may be identical, but the siRNAs could still have differential effects through translational inhibition. With all of the READ MORE
http://www.genengnews.com/rnai/rnai_supp_1.aspx

Optimizing siRNA Transfection for RNAi

Votes:8 Comments:0
Length of cell exposure to transfection agents should be optimized to minimize cellular toxicity and maximize siRNA activity by varying the amount of transfection agent and cell exposure time to trans READ MORE
http://www.ambion.com/techlib/tn/121/9.html

Effective Delivery of Functional siRNAs into Cells

Votes:16 Comments:0
Unlike other electroporators, which often require a minimum of 100,000 cells to achieve acceptable delivery and enough viable cells for analysis, we have found that the combination of our 96-well elec READ MORE
http://www.pharmagenomicsonline.com/pharmagenomics/article/articleDeta...

Efficient delivery of siRNA targeted against human papillomavirus oncogenes.

Votes:17 Comments:0
Finally, since RNAi directed against HPV18 E6/E7 has been reported to cause cellular senescence in HeLa cells (4), we monitored the typical senescence-associated spindly-cell and large-cell morphology READ MORE
http://find.galegroup.com/ips/retrieve.do...

Delivering siRNA to animal disease models for validation of novel drug targets i...

Votes:11 Comments:0
Intradigm (Rockville, Maryland, USA) has developed non-viral delivery systems for intratumoral administration of siRNA into several xenograft tumor models to knock down angiogenesis factors, resulting READ MORE
http://find.galegroup.com/ips/retrieve.do...

Cationized gelatin delivery of a plasmid DNA expressing small interference RNA f...

Votes:15 Comments:0
Cationized gelatin delivery of a plasmid DNA expressing small interference RNA for VEGF inhibits murine squamous cell carcinoma April 2006 Goichi Matsumoto, Toshihiro Kushibiki, Yukihiko Kinoshita READ MORE
http://www.blackwell-synergy.com/doi/abs/10.1111/j.1349-7006.2006.0017...

Delivery strategies for siRNA-mediated gene silencing.

Votes:28 Comments:0
Delivery strategies for siRNA-mediated gene silencing. April 2006 Gilmore IR, Fox SP, Hollins AJ, Akhtar S. PubMed RNA interference (RNAi) represents a promising new gene silencing technology fo READ MORE
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi...

siRNA-based approaches in cancer therapy.

Votes:10 Comments:0
siRNA-based approaches in cancer therapy. 2006 Jan 20 Devi GR. PubMed The availability of the human genome sequence has revolutionized the strategy of employing nucleic acids with sequences comp READ MORE
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi...

RNAi silencing of exogenous and endogenous reporter genes using a macrocyclic oc...

Votes:4 Comments:0
RNAi silencing of exogenous and endogenous reporter genes using a macrocyclic octaamine as a "compact" siRNA carrier. Studies on the nonsilenced residual activity. 2006 Jan-Feb Matsui K, Horiuchi READ MORE
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi...

New patent to enhance Sirna?s RNA production

Votes:32 Comments:0
New patent to enhance Sirna?s RNA production January 30, 2006 Kirsty Barnes In-pharma Sirna Therapeutics has been granted a US patent covering a more efficient process for the chemical synthesis READ MORE
http://www.in-pharmatechnologist.com/news/ng.asp...

Inhibiting HIV-1 infection in human T cells by lentiviral-mediated delivery of s...

Votes:37 Comments:0
Inhibiting HIV-1 infection in human T cells by lentiviral-mediated delivery of small interfering RNA against CCR5 January 7, 2003 Xiao-Feng Qin, Dong Sung An,Irvin S. Y. Chen, and David Baltimore READ MORE
http://www.pnas.org/cgi/content/full/100/1/183

Phase II Trial Starts for siRNA Therapy for Wet AMD

Votes:16 Comments:0
Phase II Trial Starts for siRNA Therapy for Wet AMD October 19, 2005 Genetic Engineering News Acuity Pharmaceuticals initiated a Phase II trial for Cand5, its lead product candidate for the treatme READ MORE
http://www.genengnews.com/stickyends/article.aspx...

siRNA-containing liposomes modified with polyarginine effectively silence the ta...

Votes:11 Comments:0
siRNA-containing liposomes modified with polyarginine effectively silence the targeted gene 15 May 2006 Chunling Zhanga, Ning Tanga,, XingJun Liua, Wei Lianga, , , Wei Xua and Vladimir P. Torchili READ MORE
http://www.sciencedirect.com/science...

A conditionally replicating HIV-based vector that stably expresses an antiviral ...

Votes:5 Comments:0
A conditionally replicating HIV-based vector that stably expresses an antiviral shRNA against HIV-1 replication Available online 11 May 2006. Ellen M. Westerhout, Monique Vink, P.C. Joost Haasnoo READ MORE
http://www.sciencedirect.com/science...

rAAV-mediated shRNA ameliorated neuropathology in Huntington disease model mouse

Votes:19 Comments:0
rAAV-mediated shRNA ameliorated neuropathology in Huntington disease model mouse 28 April 2006 Yoko Machidaa, Takashi Okadab, Masaru Kurosawaa, Fumitaka Oyamaa, Keiya Ozawab and Nobuyuki Nukina B READ MORE
http://www.sciencedirect.com/science...

Acuity Pharmaceuticals Reports Positive Initial Phase II Results For Bevasiranib...

Votes:33 Comments:0
Acuity Pharmaceuticals Reports Positive Initial Phase II Results For Bevasiranib (Cand5) In Wet AMD June 2, 2006 Acuity Pharmaceuticals Acuity Pharmaceuticals, an ophthalmic pharmaceutical compan READ MORE
http://www.acuitypharma.com/press.asp

RNAi Global Initiative Members Advance Standards For Genome-Wide RNAi Research I...

Votes:20 Comments:0
RNAi Global Initiative Members Advance Standards For Genome-Wide RNAi Research In Second Meeting May 24, 2006 Dharmacon The Genome-Wide RNAi Global Initiative (RNAi Global), an alliance of Dharmaco READ MORE
http://www.dharmacon.com/company/pressrelease.aspx...

Alnylam Gets Issued U.S. Patent Broadly Covering RNAi Therapeutics - Quick Facts

Votes:26 Comments:0
Alnylam Gets Issued U.S. Patent Broadly Covering RNAi Therapeutics - Quick Facts June 06, 2006; Trading Markets Live! RTTNews) - Alnylam Pharmaceuticals, Inc. (ALNY | charts | news | PowerRating READ MORE
http://www.tradingmarkets.com/tm.site/news/BREAKING%20NEWS/272814/

SR Pharma plc Announces a Key Technical Breakthrough With its Lyophilized (Dry P...

Votes:24 Comments:0
SR Pharma plc Announces a Key Technical Breakthrough With its Lyophilized (Dry Powder) Liposomal-Based siRNA Formulation June 6, 2006 Sr Pharma LONDON, June 6 /PRNewswire/ -- SR Pharma plc (LSE: READ MORE
http://www.srpharma.com/news/index.htm

DHARMACON and AMAXA COLLABORATE TO IMPROVE SiRNA DELIVERY INTO CELLS; Nucleofect...

Votes:32 Comments:0
DHARMACON and AMAXA COLLABORATE TO IMPROVE SiRNA DELIVERY INTO CELLS; Nucleofector Technology Enables siRNA Transfer into Primary Cells and Non-Standard Cell Lines June 6, 2006 Dharmacon LAFAYETT READ MORE
http://www.dharmacon.com/company/pressrelease.aspx...

Demonstration of two novel methods for predicting functional siRNA efficiency

Votes:11 Comments:0
Demonstration of two novel methods for predicting functional siRNA efficiency 29 May 2006 PeiLin Jia , TieLiu Shi , YuDong Cai , YiXue Li BMC Bioinformatics Abstract (provisional) Background READ MORE
http://www.biomedcentral.com/1471-2105/7/271

Designer siRNAs to overcome the challenges from the RNAi pathway

Votes:5 Comments:0
Designer siRNAs to overcome the challenges from the RNAi pathway February 2006 Sumedha D Jayasena Journal of RNAi and Gene Silencing ABSTRACT Small interfering RNA (siRNA)-based technology is READ MORE
http://www.libpubmedia.co.uk/RNAiJ-Issues/Issue-3/Jayasena.htm

RNAi-mediated gene-targeting through systemic application of polyethylenimine (P...

Votes:28 Comments:0
RNAi-mediated gene-targeting through systemic application of polyethylenimine (PEI)-complexed siRNA in vivo December 23, 2004 B Urban-Klein, S Werth, S Abuharbeid, F Czubayko and A Aigner Gene Ther READ MORE
http://www.nature.com/gt/journal/v12/n5/abs/3302425a.html

Lipid-mediated siRNA delivery down-regulates exogenous gene expression in the mo...

Votes:17 Comments:0
Lipid-mediated siRNA delivery down-regulates exogenous gene expression in the mouse brain at picomolar levels October 28, 2004 Zahra Hassani , Gregory F. Lemkine , Patrick Erbacher , Karima Palmi READ MORE
http://www3.interscience.wiley.com/cgi-bin/abstract/109741838/ABSTRACT

Potential applications for RNAi to probe pathogenesis and develop new treatments...

Votes:25 Comments:0
Potential applications for RNAi to probe pathogenesis and develop new treatments for ocular disorders 29 September 2005 P A Campochiaro Gene Therapy Abstract The eye is a relatively isolated ti READ MORE
http://www.nature.com/gt/journal/v13/n6/full/3302653a.html

Alnylam Receives New Issued U.S. Patent Broadly Covering Small Interfering RNAs ...

Votes:23 Comments:0
Alnylam Receives New Issued U.S. Patent Broadly Covering Small Interfering RNAs and Strengthens Leadership in Intellectual Property for RNAi Therapeutics July 18, 2006 CAMBRIDGE, Mass.--(BUSINES READ MORE
http://phx.corporate-ir.net/phoenix.zhtml...

Sequence-Specific Knockdown of EWS-FLI1 by Targeted, Nonviral Delivery of Small ...

Votes:35 Comments:0
Sequence-Specific Knockdown of EWS-FLI1 by Targeted, Nonviral Delivery of Small Interfering RNA Inhibits Tumor Growth in a Murine Model of Metastatic Ewing's Sarcoma October 1, 2005 Siwen Hu-Liesk READ MORE
http://cancerres.aacrjournals.org/cgi/content/abstract/65/19/8984...

Ex vivo and In vivo Delivery of Anti-Tissue Factor Short Interfering RNA Inhibit...

Votes:11 Comments:0
Ex vivo and In vivo Delivery of Anti-Tissue Factor Short Interfering RNA Inhibits Mouse Pulmonary Metastasis of B16 Melanoma Cells July 1, 2006 Mohammed Amarzguioui1, Qian Peng2,3, Merete T. Wiige READ MORE
http://clincancerres.aacrjournals.org/cgi/content/abstract/12/13/4055....

Therapeutic EphA2 Gene Targeting In vivo Using Neutral Liposomal Small Interferi...

Votes:25 Comments:0
Therapeutic EphA2 Gene Targeting In vivo Using Neutral Liposomal Small Interfering RNA Delivery August 1, 2005 Charles N. Landen, Jr.1, Arturo Chavez-Reyes2, Corazon Bucana3, Rosemarie Schmandt1, READ MORE
http://cancerres.aacrjournals.org/cgi/content/abstract/65/15/6910...

Noninvasive delivery of small inhibitory RNA and other reagents to pulmonary alv...

Votes:38 Comments:0
Noninvasive delivery of small inhibitory RNA and other reagents to pulmonary alveoli in mice July 2, 2004 Donald Massaro,1 Gloria DeCarlo Massaro,2 and Linda Biadasz Clerch Am J Physiol Lung Cell READ MORE
http://ajplung.physiology.org/cgi/content/full/287/5/L1066...

PEG conjugated VEGF siRNA for anti-angiogenic gene therapy

Votes:14 Comments:0
PEG conjugated VEGF siRNA for anti-angiogenic gene therapy 2006 Sun Hwa Kima, Ji Hoon Jeongb, Soo Hyun Leea, Sung Wan Kimb and Tae Gwan Park Journal of Controlled Release Abstract A novel siRN READ MORE
http://www.sciencedirect.com/science...

Organic?inorganic hybrid-nanocarrier of siRNA constructing through the self-asse...

Votes:28 Comments:0
Organic?inorganic hybrid-nanocarrier of siRNA constructing through the self-assembly of calcium phosphate and PEG-based block aniomer 10 April 2006 Yoshinori Kakizawaa, Sanae Furukawaa, Atushi Ish READ MORE
http://www.sciencedirect.com/science...

Transporting silence: Design of carriers for siRNA to angiogenic endothelium

Votes:3 Comments:0
Transporting silence: Design of carriers for siRNA to angiogenic endothelium 5 December 2005 Raymond M. Schiffelersa, , , Archibald J. Mixsonb, Aslam M. Ansaric, Marcel H.A.M. Fensa, Quingquan Tan READ MORE
http://www.sciencedirect.com/science...

Transfection microarray of human mesenchymal stem cells and on-chip siRNA gene k...

Votes:17 Comments:0
Transfection microarray of human mesenchymal stem cells and on-chip siRNA gene knockdown 28 April 2004 Tomohiro Yoshikawa a, Eiichiro Uchimura a, Michiko Kishi a, Daniel P. Funeriu a, Masato Miyak READ MORE
http://www.sciencedirect.com/science...

Block copolymer-coated calcium phosphate nanoparticles sensing intracellular env...

Votes:11 Comments:0
Block copolymer-coated calcium phosphate nanoparticles sensing intracellular environment for oligodeoxynucleotide and siRNA delivery 18 June 2004 Yoshinori Kakizawaa, Sanae Furukawaa and Kazunori READ MORE
http://www.sciencedirect.com/science...

Highly effective inhibition of Akabane virus replication by siRNA genes

Votes:25 Comments:0
Highly effective inhibition of Akabane virus replication by siRNA genes September 2006 Aviad Levinb, Larisa Kutznetovaa, Ronen Kahanaa, Marisol Rubinstein-Guinia and Yehuda Stram Virus Research READ MORE
http://www.sciencedirect.com/science...

A novel siRNA-lipoplex technology for RNA interference in the mouse vascular end...

Votes:21 Comments:0
A novel siRNA-lipoplex technology for RNA interference in the mouse vascular endothelium 20 April 2006 A Santel, M Aleku, O Keil, J Endruschat, V Esche, G Fisch, S Dames, K L?ffler, M Fechtner, W READ MORE
http://www.nature.com/gt/journal/v13/n16/abs/3302777a.html

Calando Pharmaceuticals Selects Agilent Technologies For siRNA Production

Votes:17 Comments:0
Calando Pharmaceuticals Selects Agilent Technologies For siRNA Production 7/26/06 Pharmaceutical Online Duarte & Palo Alto, CA - Calando Pharmaceuticals Inc., a majority-owned subsidiary of Arrow READ MORE
http://www.pharmaceuticalonline.com/content/news/article.asp...

Pathway Toward Gene Silencing Described In Plants

Votes:32 Comments:0
Pathway Toward Gene Silencing Described In Plants 7/13/2006 Bioresearch Online Biologists at Washington University in St. Louis have made an important breakthrough in understanding a pathway READ MORE
http://www.bioresearchonline.com/content/news/article.asp...

Developing new SiRNA-based therapeutics

Votes:9 Comments:0
Developing new SiRNA-based therapeutics August 17, 2006 Laboratorytalk Perbio Science reports that Abbott and Dharmacon has announced a collaboration to develop new therapeutic agents based on a READ MORE
http://www.laboratorytalk.com/news/pei/pei105.html

Focal adhesion kinase targeting using in vivo short interfering RNA delivery in ...

Votes:23 Comments:0
Focal adhesion kinase targeting using in vivo short interfering RNA delivery in neutral liposomes for ovarian carcinoma therapy 2006 Halder J; Kamat AA; Landen CN; Han LY; Lutgendorf SK; Lin YG; M READ MORE
http://www.medscape.com/medline/abstract/16914580...

Can siRNA technology provide the tools for gene therapy of the future?

Votes:23 Comments:0
Can siRNA technology provide the tools for gene therapy of the future? 2006 Racz Z, Hamar P. Curr Med Chem. A new era in genetics has started 15 years ago, when co-suppression in petunia has be READ MORE
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi...

Delivery of telomerase reverse transcriptase small interfering RNA in complex wi...

Votes:37 Comments:0
Delivery of telomerase reverse transcriptase small interfering RNA in complex with positively charged single-walled carbon nanotubes suppresses tumor growth 2006 Aug 15 Zhang Z, Yang X, Zhang Y, Z READ MORE
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi...

The Long Processes of Short Interfering RNAs - RNA Interference and Its Implicat...

Votes:13 Comments:0
The Long Processes of Short Interfering RNAs - RNA Interference and Its Implications in Neuronal Cells 2004 Lingor P, Michel U, Bahr M. Neurodegener Dis. Reverse genetics has been greatly advan READ MORE
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi...

Widespread siRNA "off-target" transcript silencing mediated by seed region seque...

Votes:32 Comments:0
Widespread siRNA "off-target" transcript silencing mediated by seed region sequence complementarity 2006 Jul Jackson AL, Burchard J, Schelter J, Chau BN, Cleary M, Lim L, Linsley PS. RNA. Tran READ MORE
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi...

In vivo siRNA delivery to the mouse hypothalamus confirms distinct roles of TR b...

Votes:19 Comments:0
In vivo siRNA delivery to the mouse hypothalamus confirms distinct roles of TR beta isoforms in regulating TRH transcription 2006 Aug 21 Guissouma H, Froidevaux MS, Hassani Z, Demeneix BA. Neuro READ MORE
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi...

An effective method for adenoviral-mediated delivery of small interfering RNA in...

Votes:14 Comments:0
An effective method for adenoviral-mediated delivery of small interfering RNA into mesenchymal stem cells 2006 Aug 3 Forte A, Napolitano MA, Cipollaro M, Giordano A, Cascino A, Galderisi U. J Ce READ MORE
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi...

A peptidomimetic siRNA transfection reagent for highly effective gene silencing

Votes:27 Comments:0
A peptidomimetic siRNA transfection reagent for highly effective gene silencing 2006 Jun Utku Y, Dehan E, Ouerfelli O, Piano F, Zuckermann RN, Pagano M, Kirshenbaum K. Mol Biosyst. RNA interfe READ MORE
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi...

Intratumor injection of small interfering RNA-targeting human papillomavirus 18 ...

Votes:3 Comments:0
Intratumor injection of small interfering RNA-targeting human papillomavirus 18 E6 and E7 successfully inhibits the growth of cervical cancer 2006 Sep Fujii T, Saito M, Iwasaki E, Ochiya T, Takei READ MORE
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi...

Ligand-Targeted Delivery of Therapeutic siRNA

Votes:36 Comments:0
Ligand-Targeted Delivery of Therapeutic siRNA 2006 Jul 19 Ikeda Y, Taira K. Pharm Res. RNA interference (RNAi) is a post-transcriptional gene-silencing phenomenon that is triggered by double-s READ MORE
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi...

Nastech Wins Phase I SBIR Grant to Develop siRNA-Based Flu Drugs

Votes:9 Comments:0
Nastech Wins Phase I SBIR Grant to Develop siRNA-Based Flu Drugs August 29, 2006 GenomeWeb NEW YORK (GenomeWeb News) ? Nastech Pharmaceutical has obtained a Phase I Small Business Innovation Res READ MORE
http://www.genomeweb.com/issues/news/134715-1.html

Invitrogen Introduces Next Generation of Transfection Reagents; Lipofectamine(TM...

Votes:22 Comments:0
Invitrogen Introduces Next Generation of Transfection Reagents; Lipofectamine(TM) LTX Reagent Improves DNA Delivery and Lowers Toxicity August 30, 2006 Invitrogen CARLSBAD, Calif.--(BUSINESS WIR READ MORE
http://phx.corporate-ir.net/phoenix.zhtml...

Nanoparticles Successfully Deliver Protein-Suppressing RNA-Based Therapies

Votes:12 Comments:0
Nanoparticles Successfully Deliver Protein-Suppressing RNA-Based Therapies 9/3/2006 nanotechwire.com Small pieces of nucleic acid, known as siRNAs (short interfering RNAs), can turn off the prod READ MORE
http://nanotechwire.com/news.asp...

Increased sensitivity to chemotherapeutic drug by RNAi targeting Hsp701A in HepG...

Votes:6 Comments:0
Increased sensitivity to chemotherapeutic drug by RNAi targeting Hsp701A in HepG2 cells September 2006 Zhu Q, Zhang WG, Wang LF, Wang F, Zhang Y, Yang AG PubMed AIM: To investigate the effects o READ MORE
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi...

An siRNA-based microbicide protects mice fromlethal herpes simplex virus 2 infec...

Votes:15 Comments:0
An siRNA-based microbicide protects mice fromlethal herpes simplex virus 2 infection January 2006 Deborah Palliser Dipanjan Chowdhury Qing-Yin Wang, Sandra J. Lee, Roderick T. Bronson,David M. Knipe READ MORE
http://idp.med.ufl.edu/Core/Spring/6006/D7_HSV2.pdf.

The antisense strand of small interfering RNAs directs histone methylation and t...

Votes:34 Comments:0
The antisense strand of small interfering RNAs directs histone methylation and transcriptional gene silencing in human cells December, 2005 MARC S. WEINBERG, LOUISA M. VILLENEUVE, ALI EHSANI, MOHA READ MORE
http://www.rnajournal.org/cgi/content/abstract/12/2/256

Cleavage of the siRNA passenger strand during RISC assembly in human cells.

Votes:9 Comments:0
Cleavage of the siRNA passenger strand during RISC assembly in human cells. January 2006 Leuschner PJ, Ameres SL, Kueng S, Martinez J. PubMed A crucial step in the RNA interference (RNAi) pathwa READ MORE
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi...

siRNA in human cells selectively localizes to target RNA sites

Votes:34 Comments:0
siRNA in human cells selectively localizes to target RNA sites May 16, 2006 Svitlana Y. Berezhna, Lubica Supekova, Frantisek Supek, Peter G. Schultz, and Ashok A. Deniz PNAS Recent observations READ MORE
http://www.pnas.org/cgi/content/abstract/103/20/7682...

Transglutaminase Participates in UVB-Induced Cell Death Pathways in Human Cornea...

Votes:4 Comments:0
Transglutaminase Participates in UVB-Induced Cell Death Pathways in Human Corneal Epithelial Cells 2006 Oct Tong L, Chen Z, De Paiva CS, Beuerman R, Li DQ, Pflugfelder SC. Invest Ophthalmol Vis S READ MORE
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi...

Integrated DNA Technologies: Integrated DNA Technologies Acquires Belgian Manufa...

Votes:33 Comments:0
Integrated DNA Technologies: Integrated DNA Technologies Acquires Belgian Manufacturer RNA-TEC 9/0/06 Bioresearch Online Purchase Expands IDT?s Large-Scale RNA Synthesis Capabilities; Builds Pres READ MORE
http://www.bioresearchonline.com/content/news/article.asp...

Nastech awarded grant for siRNA therapeutics for flu

Votes:17 Comments:0
Nastech awarded grant for siRNA therapeutics for flu 08/30/2006 By Wai Lang Chu DrugResearcher.com The National Institute of Allergy and Infectious Diseases (NIAID) has awarded Nastech Pharmace READ MORE
http://www.drugresearcher.com/news/ng.asp...
siRNA - Protein Synthesis
Autism Library , Cell Biology Homework
Sites of Interest
Solar Market Intelligence
-
Search
Search
Search
Search
Login
StudySphere
Privacy Policy